Delivery Order SPE2DB22D2206-SPE2DB23FJT77

Award Date 8/14/23
Potential Completion Date 8/15/23
Potential Value $527
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $7,006.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562007332 OMNIPAQUE 300 MG/ML VIAL 10ML. As the prime contractor, Amerisourcebergen will deliver this contrast agent to locations within Conshohocken, Pennsylvania by September 1, 2023 in support of the Defense Logistics Agency's medical supply chain requirements. No subcontractors or set aside designations were identified for this delivery order placed under an existing...
The Defense Logistics Agency awarded a $50,260 delivery order to Amerisourcebergen Drug Corporation for 4561357227 OMNIPAQUE 350 MG/ML INFU BTL 100ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide contrast media to support Department of Defense medical programs. Performance will occur at Amerisourcebergen's facilities in Conshohocken, Pennsylvania over a one day period from June 27 to June 28, 2023. No subcontractors or set aside...
The Defense Logistics Agency awarded a $50,260 delivery order to Amerisourcebergen Drug Corporation for OMNIPAQUE 350 MG/ML injectable bottles. The firm fixed price order is for 100mL bottles of the contrast agent and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by July 25, 2023. As a major supplier of medical products to the Department of Defense, this award provides a critical diagnostic tool to DLA and its customer base under an existing...
The Defense Logistics Agency awarded a $301.56 delivery order to Amerisourcebergen Drug Corporation for 4561292138 OMNIPAQUE 350 MG/ML INFU BTL 100ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply contrast media and related medical products to military treatment facilities. Performance will take place in Conshohocken, Pennsylvania from June 20-21, 2023. No subcontractors or set aside designations were specified. The Defense Logistics...
The Defense Logistics Agency awarded a $301.56 delivery order to Amerisourcebergen Drug Corporation for 4562217440 OMNIPAQUE 350 MG/ML INFU BTL 100ML. The firm fixed price order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen. Performance will take place in Conshohocken, Pennsylvania from September 18-19, 2023. No set aside designation or subcontractors were indicated. The DLA supports Department of Defense procurement and supply...
The Defense Logistics Agency awarded a $34,320 delivery order to Amerisourcebergen Drug Corporation for 4561531612 OMNIPAQUE 300 MG/ML PLUSPAK 30ML. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and calls for the delivery of contrast media to a Defense Logistics Agency facility in Conshohocken, Pennsylvania. Funding is being provided by the Defense Logistics Agency to support its medical supply needs. No subcontractors or set aside designations...
The Defense Logistics Agency awarded a $150,780 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OMNIPAQUE 350 MG/ML injectable bottles. As the prime contractor, Amerisourcebergen will deliver one hundred milliliter bottles of the contrast agent to a facility in Conshohocken, Pennsylvania by July 28, 2023 in support of the Defense Logistics Agency's medical supply procurement programs. No subcontractors or set aside designations were identified. The delivery order was...
The Defense Logistics Agency awarded a $100,520 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OMNIPAQUE 350 MG/ML injectable bottles. The prime contractor will deliver 100mL bottles of the contrast agent to a facility in Conshohocken, Pennsylvania between July 31, 2023 and August 1, 2023. As a major component of the Department of Defense that manages global logistics operations for the Army, Navy, Air Force, Marine Corps, and Coast Guard, this delivery order for...
The Defense Logistics Agency awarded a $251,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561412086 OMNIPAQUE 240 MG/ML VIAL 10ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested contrast media to a facility located in Conshohocken, Pennsylvania. The Department of Defense agency issued the order under an unspecified multiple award contract vehicle. Performance will take place between July 5-6, 2023....
Defense Logistics Agency awarded a $755 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for OMNIPAQUE 240 MG/ML VIAL 10ML. The order was issued on October 17, 2023 with a completion date of October 18, 2023. Place of performance will be in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. Defense Logistics Agency supports America's armed forces by delivering nearly $21 billion in effective and...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB23FJT77
    Delivery Order

The Defense Logistics Agency awarded a $526.60 delivery order to Amerisourcebergen Drug Corporation for 4561807701 OMNIPAQUE 180 MG/ML VIAL 10ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for delivery of the contrast agent to a facility in Conshohocken, Pennsylvania by August 15, 2023. As the DLA supports medical readiness for the U.S. Department of Defense, this contract will likely provide imaging materials to a military treatment center or similar organization. No subcontractors or set aside designations were specified.

Generated 12/15/23, 3:44 AM